Jun 2, 2015 07:41AM Roth Capital Remains Bullish on Curis (CRIS) Following '907 Presentation at ASCO

Mar 2, 2015 04:00PM Curis Announces Closing of Public Offering of Common Stock

Feb 25, 2015 08:10AM Curis (CRIS) Prices 21.8M Common Offering at $2.75/Share

Feb 25, 2015 08:08AM Curis Prices Public Offering of Common Stock

Feb 24, 2015 04:00PM Curis Reports Fourth Quarter and Year-End 2014 Financial Results

Jan 21, 2015 02:30PM Roth Affirms Curis (CRIS) at 'Buy' Following Aurigene Deal; Cuts PT to $6 on Dilution

Dec 18, 2014 10:52AM Roth Capital 'Favorable' on Curis' (CRIS) CUDC-907 Following Phase 1 Initiation in a/r Solid Tumors

Nov 10, 2014 02:34PM Roth Affirms Curis (CRIS) at 'Buy' Following Q3 Report, Update; Pipeline Progress is Encouraging

Oct 28, 2014 12:06PM Streetinsider.com's Hot Lunchtime Reads 10/28: (GT) (NE) (COH) (CRIS)

Oct 28, 2014 11:47AM Curis' (CRIS) CUDC-907 IP Protection 'Strong' Following Latest Allowance - Roth Capital

Oct 16, 2014 02:22PM Roth Capital Positive on Curis (CRIS) Following Q3 Results from Roche/Erivedge

Oct 2, 2014 09:39AM Recent Moves by Curis (CRIS) May Increase Value of CUDC-907 - Roth Capital

Jun 4, 2014 04:23PM Culture Still Intact at Curis (CRIS) Following Management Shift; Roth Affirms at 'Buy'

May 8, 2014 02:18PM Curis' (CRIS) Q1 Results Flat; Erivedge Growth, Pipeline Remain in Focus - Roth

Mar 31, 2014 08:39AM Roth Boosts PT on Curis (CRIS) to $10; '427 Overhang Now Lifted

Mar 24, 2014 07:46AM Roth Cuts PT on Curis (CRIS) to $9; Erivedge Phase 2 Misses Roche's (RHHBY) Internal Expectations

Feb 24, 2014 11:33AM Roth Reaffirms Curis (CRIS) at Buy; Erivedge, Internal Pipeline Both Ongoing Strengths

Feb 20, 2014 07:00AM Curis Reports Fourth Quarter and Year-End 2013 Financial Results

Jul 8, 2011 09:42AM Roth Capital Upgrades Curis (CRIS) to Buy

Jan 22, 2010 10:40AM Morning Movers 1/22: SOMX, LGN, STBK, PIP, WHRT, TRGL Higher; CRIS, DEAR, MBHI, ISR, AMD, ACHN Lower

Jan 7, 2010 07:53AM Roth Capital Initiates Coverage on Biotechnology and Drugs Stocks